Login / Signup

Management of ALL in Adults: 2023 ELN Recommendations from a European Expert Panel.

Nicola GökbugetNicolas BoisselSabina ChiarettiHerve DombretMichael DoubekAdele K FieldingRobin FoàSebastian GiebelDieter HoelzerMathilde M Hunault-BergerDavid I MarksGiovanni MartinelliOliver OttmannAnita W RijneveldPhilippe RousselotJosep-María RiberaRenato Bassan
Published in: Blood (2024)
Experts from the European Leukemia Net (ELN) working group for adult acute lymphoblastic leukemia have identified an unmet need for guidance regarding management of adult ALL from diagnosis to aftercare. The group has previously summarized their recommendations regarding diagnostic approaches, prognostic factors and assessment of ALL (cross-reference). The current recommendation summarizes clinical management. It covers treatment approaches including the use of new immunotherapies, application of MRD for treatment decisions, management of specific subgroups and challenging treatment situations as well as late effects and supportive care. The recommendation provides guidance for physicians caring for adult ALL patients which has to be complemented by regional expertise preferably provided by national academic study groups.
Keyphrases
  • prognostic factors
  • acute lymphoblastic leukemia
  • primary care
  • healthcare
  • newly diagnosed
  • young adults
  • clinical practice
  • pain management
  • chronic pain
  • allogeneic hematopoietic stem cell transplantation